Abstract
For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.
All Keywords
【초록키워드】 Hospitalization, COVID‐19, cancers, Patient, hematology, mortality rate, registry, Blood, 【제목키워드】 COVID-19, registry, insight,
【초록키워드】 Hospitalization, COVID‐19, cancers, Patient, hematology, mortality rate, registry, Blood, 【제목키워드】 COVID-19, registry, insight,
{{{ 추상적인 }}}
ASH Research Collaborative COVID-19 Registry for Hematology의 새로운 데이터에 따르면 혈액암 환자의 경우 COVID-19 사망률은 전체적으로 약 20%, 입원이 필요한 환자의 경우 33%입니다.